Drug Shortage Report for DEXTROSE INJECTION USP
Report ID | 203374 |
Drug Identification Number | 00037966 |
Brand name | DEXTROSE INJECTION USP |
Common or Proper name | Dextrose Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL in 1000 mL Container |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-27 |
Estimated end date | |
Actual end date | 2023-11-01 |
Shortage status | Resolved |
Updated date | 2023-11-02 |
Company comments | Discontinued 11/1/2023 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-11-02 | English | Compare |
v7 | 2023-11-01 | French | Compare |
v6 | 2023-11-01 | English | Compare |
v5 | 2023-11-01 | French | Compare |
v4 | 2023-11-01 | English | Compare |
v3 | 2023-08-31 | French | Compare |
v2 | 2023-08-31 | English | Compare |
v1 | 2023-08-31 | English | Compare |
Showing 1 to 8 of 8